Why isn't endogenous ouabain more widely accepted?

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 307, Issue 5, 2014, Pages

  Blaustein, Mordecai P ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; CARDIOVASCULAR SYSTEM; HUMANS; OUABAIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 84906920517     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00404.2014     Document Type: Article

References (63)

1. Anderson DE, Gomez-Sanchez C, Dietz JR. Suppression of plasma renin and aldosterone in stress-salt hypertension in dogs. Am J Physiol Regul Integr Comp Physiol 251: R181-R186, 1986.
2. Baecher S, Kroiss M, Fassnacht M, Vogeser M. No endogenous ouabain is detectable in human plasma by ultra-sensitive UPLC-MS/MS. Clin Chim Acta 431: 87-92, 2014.
3. + regulation in normal and failing hearts. J Pharmacol Sci 100: 315-322, 2006.
4. Bignami E, Casamassima N, Frati E, Lanzani C, Corno L, Alfieri O, Gottlieb S, Simonini M, Shah KB, Mizzi A, Messaggio E, Zangrillo A, Ferrandi M, Ferrari P, Bianchi G, Hamlyn JM, Manunta P. Preoperative endogenous ouabain predicts acute kidney injury in cardiac surgery patients. Crit Care Med 41: 744-755, 2013.
5. Blanco G, Mercer RW. Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. Am J Physiol Renal Physiol 275: F633-F650, 1998.
6. 2+ exchanger and TRPC proteins. Biochim Biophys Acta 1082: 1219-1229, 2010.
7. Blaustein MP, Leenen FH, Chen L, Golovina VA, Hamlyn JM, Pallone TL, Van Huysse JW, Zhang J, Wier WG. How NaCl raises blood pressure: a new paradigm for the pathogenesis of salt-dependent hypertension. Am J Physiol Heart Circ Physiol 302: H1031-H1049, 2012.
8. + ATPase α2 but not α1 isoform attenuates pathological cardiac hypertrophy and remodeling. Circ Res 114: 249-256, 2014.
9. Darwin C. The Origin of Species by Means of Natural Selection; or, The Preservation of Favored Races in the Struggle for Life and the Descent of Man and Selection in Relation to Sex. New York: Modern Library, 1936, Chapt. XV, p. 368.
10. Digitalis Investigative Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336: 525-533, 1997.
11. Doris PA, Jenkins LA, Stocco DM. Is ouabain an authentic endogenous mammalian substance derived from the adrenal? Hypertension 23: 632-638, 1994.
12. Dostanic-Larson I, Van Huysse JW, Lorenz JN, Lingrel JB. The highly conserved cardiac glycoside binding site of Na, K-ATPase plays a role in blood pressure regulation. Proc Natl Acad Sci USA 102: 15845-15850, 2005.
13. 2-isoform of Na-K-ATPase mediates ouabain-induced hypertension in mice and increased vascular contractility in vitro. Am J Physiol Heart Circ Physiol 288: H477-H485, 2005.
14. + pump and the brain renin-angiotensin system. Clin Exp Hypertens A 14: 393-411, 1992.
15. Einstein A, Born M, Born H. A. Einstein letter to M. Born, 4 Dec. 1926. In: The Born-Einstein Letters: Correspondence Between Albert Einstein and Max and Hedwig Born from 1916 to 1955. New York: Walker, 1971, p. 91.
16. Felder RB, Francis J, Weiss RM, Zhang ZH, Wei SG, Johnson AK. Neurohumoral regulation in ischemia-induced heart failure. Role of the forebrain. Ann NY Acad Sci 940: 444-453, 2001.
17. Ferrandi M, Manunta P, Balzan S, Hamlyn JM, Bianchi G, Ferrari P. Ouabain-like factor quantification in mammalian tissues and plasma: comparison of two independent assays. Hypertension 30: 886-896, 1997.
18. Gabor A, Leenen FH. Central neuromodulatory pathways regulating sympathetic activity in hypertension. J Appl Physiol 113: 1294-1303, 2012.
19. Gomez-Sanchez EP, Fort C, Thwaites D. Central mineralocorticoid receptor antagonism blocks hypertension in Dahl S/JR rats. Am J Physiol Endocrinol Metab 262: E96-E99, 1992.
20. Gomez-Sanchez EP, Gomez-Sanchez CE. Effect of central amiloride infusion on mineralocorticoid hypertension. Am J Physiol Endocrinol Metab 267: E754-E758, 1994.
21. Gottlieb SS, Rogowski AC, Weinberg M, Krichten CM, Hamilton BP, Hamlyn JM. Elevated concentrations of endogenous ouabain in patients with congestive heart failure. Circulation 86: 420-425, 1992.
22. Hamlyn JM, Blaustein MP. Salt sensitivity, endogenous ouabain and hypertension. Curr Opin Nephrol Hypertens 22: 51-58, 2013.
23. Hamlyn JM, Blaustein MP, Bova S, DuCharme DW, Harris DW, Mandel F, Mathews WR, Ludens JH. Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci USA 88: 6259-6263, 1991.
24. Hamlyn JM, Leenen FH, Golovina VA, Linde CI, Gao J, Huang B, Chen L, Li M, Blaustein MP. Central angiotensin II increases circulating endogenous ouabain, arterial myocyte Na/Ca exchanger expression and blood pressure via brain aldosterone and mineralocorticoid receptors. Hypertension 60: e419, 2012.
25. Huang BS, Harmsen E, Yu H, Leenen FH. Brain ouabain-like activity and the sympathoexcitatory and pressor effects of central sodium in rats. Circ Res 71: 1059-1066, 1992.
26. Huang BS, Kudlac M, Kumarathasan R, Leenen FH. Digoxin prevents ouabain and high salt intake-induced hypertension in rats with sinoaortic denervation. Hypertension 34: 733-738, 1999.
27. Jiang X, Ren YP, Lv ZR. Ouabain induces cardiac remodeling in rats independent of blood pressure. Acta Pharmacol Sin 28: 344-352, 2007.
28. Kuhn TS. The Structure of Scientific Revolutions. Chicago: University of Chicago Press, 1996, p. 144-159.
29. Leenen FH. Actions of circulating angiotensin ii and aldosterone in the brain contributing to hypertension. Am J Hypertens. 17 Apr 2014. [Epub ahead of print].
30. Leenen FH. The central role of the brain aldosterone-"ouabain" pathway in salt-sensitive hypertension. Biochim Biophys Acta 1802: 1132-1139, 2010.
31. Leenen FH, Huang BS, Yu H, Yuan B. Brain 'ouabain' mediates sympathetic hyperactivity in congestive heart failure. Circ Res 77: 993-1000, 1995.
32. 2+ signaling in human arterial myocytes: a mechanism that links salt to increased vascular resistance? Am J Physiol Heart Circ Physiol 303: H784-H794, 2012.
33. Lingrel JB, Orlowski J, Shull MM, Price EM. Molecular genetics of Na, K-ATPase. Prog Nucleic Acid Res Mol Biol 38: 37-89, 1990.
34. +-ATPase subunit. Am J Physiol Heart Circ Physiol 295: H273-H280, 2008.
35. Manunta P, Ferrandi M, Bianchi G, Hamlyn JM. Endogenous ouabain in cardiovascular function and disease. J Hypertens 27: 9-18, 2009.
36. Manunta P, Hamilton BP, Hamlyn JM. Salt intake and depletion increase circulating levels of endogenous ouabain in normal men. Am J Physiol Regul Integr Comp Physiol 290: R553-R559, 2006.
37. Manunta P, Hamilton J, Rogowski AC, Hamilton BP, Hamlyn JM. Chronic hypertension induced by ouabain but not digoxin in the rat: antihypertensive effect of digoxin and digitoxin. Hypertens Res 23 Suppl: S77-S85, 2000.
38. Manunta P, Tyzack J, Hamilton BP, Hamlyn JM. Augmentation and antagonism of ouabain-induced hypertension. Hypertension 22: 432, 1993.
39. +-ATPase to ERK1/2. J Biol Chem 276: 42050-42056, 2001.
40. Nicholls MG, Lewis LK, Yandle TG, Lord G, McKinnon W, Hilton PJ. Ouabain, a circulating hormone secreted by the adrenals, is pivotal in cardiovascular disease. Fact or fantasy? J Hypertens 27: 3-8, 2009.
41. O'Brien WJ, Lingrel JB, Wallick ET. Ouabain binding kinetics of the rat alpha two and alpha three isoforms of the sodium-potassium adenosine triphosphate. Arch Biochem Biophys 310: 32-39, 1994.
42. O'Rourke B, Kass DA, Tomaselli GF, Kaab S, Tunin R, Marban E. Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, I: experimental studies. Circ Res 84: 562-570, 1999.
43. Osborn JW, Fink GD, Sved AF, Toney GM, Raizada MK. Circulating angiotensin II and dietary salt: converging signals for neurogenic hypertension. Curr Hypertens Rep 9: 228-235, 2007.
44. Pare MC, Maltais S, Escher E. The neurogenic origin of hypertension in SHR may be mediated by angiotensin II through a receptor different from AT1 and AT2. Regul Pept 47: 81-86, 1993.
45. 2+-dependent expressions of early-response genes in cardiac myocytes. J Biol Chem 271: 10372-10378, 1996.
46. Pitzalis MV, Hamlyn JM, Messaggio E, Iacoviello M, Forleo C, Romito R, de Tommasi E, Rizzon P, Bianchi G, Manunta P. Independent and incremental prognostic value of endogenous ouabain in idiopathic dilated cardiomyopathy. Eur J Heart Fail 8: 179-186, 2006.
47. 2+ exchanger-1 and TRPC/Orai-containing channels: key players in arterial hypertension. Adv Exp Med Biol 961: 365-374, 2013.
48. 2+ transporters in arterial smooth muscle from ouabain-induced hypertensive rats. Am J Physiol Heart Circ Physiol 298: H263-H274, 2010.
49. +-ATPase function in caveolin-1 knockout cardiac fibroblasts. J Mol Cell Cardiol 49: 525-531, 2010.
50. 2-isoform in the cardiovascular system does not alter basal blood pressure but prevents ACTH-induced hypertension. Am J Physiol Heart Circ Physiol 301: H1396-H1404, 2011.
51. 2-isoform in cardiac myocytes delays pressure overload-induced cardiac dysfunction. Am J Physiol Heart Circ Physiol 304: H1147-H1158, 2013.
52. Rossi G, Manunta P, Hamlyn JM, Pavan E, De Toni R, Semplicini A, Pessina AC. Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels. J Hypertens 13: 1181-1191, 1995.
53. 2-isoform specifically couples to contractility in vascular smooth muscle: evidence from gene-targeted neonatal mice. Am J Physiol Cell Physiol 286: C813-C820, 2004.
54. Simonini M, Lanzani C, Bignami E, Casamassima N, Frati E, Meroni R, Messaggio E, Alfieri O, Hamlyn J, Body SC, Collard CD, Zangrillo A, Manunta P. A new clinical multivariable model that predicts postoperative acute kidney injury: impact of endogenous ouabain. Nephrol Dial Transplant. 11 Jun 2014. pii: gfu200. [Epub ahead of print].
55. Song H, Karashima E, Hamlyn JM, Blaustein MP. Ouabain-digoxin antagonism in rat arteries and neurones. J Physiol 592: 941-969, 2014.
56. 2+ signalling in rat hippocampal neurones and glia. J Physiol 591: 1671-1689, 2013.
57. Stella P, Manunta P, Mallamaci F, Melandri M, Spotti D, Tripepi G, Hamlyn JM, Malatino LS, Bianchi G, Zoccali C. Endogenous ouabain and cardiomyopathy in dialysis patients. J Intern Med 263: 274-280, 2008.
58. 2+ exchanger in end-stage human heart failure. Circ Res 75: 443-453, 1994.
59. Yoda A. Association and dissociation rate constants of the complexes between various cardiac monoglycosides and Na, K-ATPase. Ann NY Acad Sci 242: 598-616, 1974.
60. Yuan CM, Manunta P, Hamlyn JM, Chen S, Bohen E, Yeun J, Haddy FJ, Pamnani MB. Long-term ouabain administration produces hypertension in rats. Hypertension 22: 178-187, 1993.
61. Zhang J, Lee MY, Cavalli M, Chen L, Berra-Romani R, Balke CW, Bianchi G, Ferrari P, Hamlyn JM, Iwamoto T, Lingrel JB, Matteson DR, Wier WG, Blaustein MP. Sodium pump α2 subunits control myogenic tone and blood pressure in mice. J Physiol 569: 243-256, 2005.
62. Zucker IH, Xiao L, Haack KK. The central renin-angiotensin system and sympathetic nerve activity in chronic heart failure. Clin Sci (Lond) 126: 695-706, 2014.
63. 2+ signaling in arterial smooth muscle cells. Am J Physiol Cell Physiol 304: C324-C333, 2013.